Carlo Sistilli - May 29, 2025 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Director
Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Carlo Sistilli
Stock symbol
EDSA
Transactions as of
May 29, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 09:24 PM
Previous filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sistilli Carlo Director C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA /s/ Peter J. Weiler, Attorney-in-Fact for Carlo Sistilli 2025-06-02 0001777988

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award $0 +20K +192.02% $0.00 30.4K May 29, 2025 Direct F1
holding EDSA Common Shares 522 May 29, 2025 Held by York-Cav Enterprises, Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
F2 York-Cav Enterprises, Inc. is partially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit 24 - Power of Attorney